Cargando...
More Haste, Less Speed: Could Public–Private Partnerships Advance Cellular Immunotherapies?
Cellular immunotherapies promise to transform cancer care. However, they must overcome serious challenges, including: (1) the need to identify and characterize novel cancer antigens to expand the range of therapeutic targets; (2) the need to develop strategies to minimize serious adverse events, suc...
Guardado en:
| Publicado en: | Front Med (Lausanne) |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5561330/ https://ncbi.nlm.nih.gov/pubmed/28861415 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2017.00134 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|